404 related articles for article (PubMed ID: 19721131)
1. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.
Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U
J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
Thanikachalam S; Manchanda SC
Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
[TBL] [Abstract][Full Text] [Related]
5. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
7. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
[TBL] [Abstract][Full Text] [Related]
8. Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgery.
Boodhwani M; Rubens FD; Wozny D; Rodriguez R; Alsefaou A; Hendry PJ; Nathan HJ
Circulation; 2006 Jul; 114(1 Suppl):I461-6. PubMed ID: 16820619
[TBL] [Abstract][Full Text] [Related]
9. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
[TBL] [Abstract][Full Text] [Related]
10. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction?
Qiu ZB; Chen X; Xu M; Shi KH; Jiang YS; Xiao LQ
Chin Med J (Engl); 2008 Dec; 121(23):2397-402. PubMed ID: 19102956
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for prolonged ICU stay in patients following coronary artery bypass grafting with a long duration of cardiopulmonary bypass.
Nakasuji M; Matsushita M; Asada A
J Anesth; 2005; 19(2):118-23. PubMed ID: 15875128
[TBL] [Abstract][Full Text] [Related]
12. The effect of preoperative circadian blood pressure pattern on early postoperative outcomes in patients with coronary artery bypass graft surgery.
Bahçivan M; Gülel O; Kolbakir F
Anadolu Kardiyol Derg; 2008 Oct; 8(5):354-9. PubMed ID: 18849227
[TBL] [Abstract][Full Text] [Related]
13. Predicting prolonged intensive care unit length of stay in patients undergoing coronary artery bypass surgery--development of an entirely preoperative scorecard.
Herman C; Karolak W; Yip AM; Buth KJ; Hassan A; Légaré JF
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):654-8. PubMed ID: 19640868
[TBL] [Abstract][Full Text] [Related]
14. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
15. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
[TBL] [Abstract][Full Text] [Related]
16. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
[TBL] [Abstract][Full Text] [Related]
17. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients.
Twersky RS; Goel V; Narayan P; Weedon J
Anesth Analg; 2014 May; 118(5):938-44. PubMed ID: 24681657
[TBL] [Abstract][Full Text] [Related]
18. Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery?
Gunay R; Sensoz Y; Kayacioglu I; Tuygun AK; Balci AY; Kisa U; Demirtas MM; Yekeler I
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):630-4. PubMed ID: 19625469
[TBL] [Abstract][Full Text] [Related]
19. Predictors and outcome of ICU readmission after cardiac surgery.
Litmathe J; Kurt M; Feindt P; Gams E; Boeken U
Thorac Cardiovasc Surg; 2009 Oct; 57(7):391-4. PubMed ID: 19795324
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Pretorius M; Murphey LJ; McFarlane JA; Vaughan DE; Brown NJ
Circulation; 2003 Dec; 108(25):3079-83. PubMed ID: 14656921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
